Ann Surg Oncol

1. HORINO T, Komori K, Ishikawa Y, Kataoka K, et al
   Prognostic Role of Pretreatment Nutritional and Inflammatory Status in Unresectable Metastatic Colorectal Cancer: Supplementary Analysis of JCOG1007.
   Ann Surg Oncol. 2026 Sep 21. doi: 10.1245/s10434-026-20608.
   

   >> Share

   
   

   
   BMC Cancer

2. HAN Z, Zhang B, Liu S, Wu T, et al
   Comparative effectiveness of neoadjuvant therapy combined with stent placement versus stent alone in obstructive colorectal cancer: a multicenter retrospective analysis.
   BMC Cancer. 2026;26:1139.
   

   >> Share

   
   

   
   BMJ Oncol

3. NAKAZAWA N, Matsuda K, Ugai S, Miyahara S, et al
   Cytotoxic T-cell exhaustion analyses by in situ single-cell immunofluorescence in relation to colorectal cancer patient age, tissue bacteria and mortality.
   BMJ Oncol. 2026;5:e001159.
   

   >> Share

   
   

   
   Cancer Lett

4. DAI S, Liu Z, Sun J, He Y, et al
   MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis.
   Cancer Lett. 2026;660:218847.
   

   >> Share

   
   

   
   Cancer Res

5. ZHANG D, Chen H, Gu L, Ding X, et al
   Mesenchymal Tumors Feature a Spatially Defined Glial-Tip Cell Niche Around the Tumor Boundary in Microsatellite-Stable Colorectal Cancer.
   Cancer Res. 2026 Sep 21. doi: 10.1158/0008-5472.CAN-25-5619.
   

   >> Share

   
   

   
   Dig Dis

6. ZHANG K, Chen Z
   Comprehensive analysis of colorectal cancer burden in G20 countries from 1990 to 2023 and projections to 2030: findings from the Global Burden of Disease Study 2023.
   Dig Dis. 2026 Sep 24:1. doi: 10.1159.
   

   >> Share

   
   

   
   Dis Colon Rectum

7. BHATTACHARYA A, Schultz KS, Yun SW, Hughes ML, et al
   Neighborhood Food Environment and Early-Onset Colorectal Cancer Survival.
   Dis Colon Rectum. 2026 Sep 25. doi: 10.1097/DCR.0000000000004473.
   

   >> Share

   
   
8. HUANG SF, Hsu CW, Chen YH, Wu CC, et al
   Ruling Out Early Distant Recurrence in Stage III Colon Cancer: A Simple 4-Variable Machine Learning Model with External Validation.
   Dis Colon Rectum. 2026 Sep 25. doi: 10.1097/DCR.0000000000004456.
   

   >> Share

   
   
9. CURRAN T
   Research Perspective on Delays in Diagnosis of Early-Onset Colorectal Cancer Across the United States: A Systematic Review.
   Dis Colon Rectum. 2026 Sep 23. doi: 10.1097/DCR.0000000000004477.
   

   >> Share

   
   
10. INOUE K, Misawa N, Suzuki H, Tamura S, et al
    Efficacy of Preoperative Colonoscopy Following Self-Expandable Metallic Stent Placement in Patients with Obstructive Colorectal Cancer.
    Dis Colon Rectum. 2026 Sep 23. doi: 10.1097/DCR.0000000000004421.
    

    >> Share

    
    
11. AL KHALDI M, Emile SH
    Early-Onset Colorectal Cancer: Contemporary Management, Immunotherapy, and Organ Preservation.
    Dis Colon Rectum. 2026 Sep 23. doi: 10.1097/DCR.0000000000004479.
    

    >> Share

    
    
12. DIONIGI B
    Expert Commentary on Early-Onset Colorectal Cancer: Contemporary Management, Immunotherapy, and Organ Preservation.
    Dis Colon Rectum. 2026 Sep 23. doi: 10.1097/DCR.0000000000004478.
    

    >> Share

    
    

    
    Eur J Surg Oncol

13. NG JC, Sassun R, Sileo A, Koneru S, et al
    Oncologic outcomes of watch-and-wait compared to tumor regression grades after total mesorectal excision in rectal cancer.
    Eur J Surg Oncol. 2026;52:112024.
    

    >> Share

    
    
14. BAO QR, Pulvirenti A, Parati C, Battisti G, et al
    Delayed total mesorectal excision after rectal-sparing strategies, oncologic safety and surgical outcomes: a propensity score-matched study from ReSARCh trial.
    Eur J Surg Oncol. 2026;52:111965.
    

    >> Share

    
    
15. GOOIJER SA, Schneiders FL, Dickhoff C, Tuynman JB, et al
    Assessing actionable radiological features on serial CT images in Post-SABR patients with resected local recurrence of colorectal lung metastases.
    Eur J Surg Oncol. 2026;52:111998.
    

    >> Share

    
    
16. KNIGHT KA, Brennan KE, McKechnie TJ, Kong W, et al
    Revisiting the rationale for radical resection in low-risk early rectal cancer: a population-level perspective.
    Eur J Surg Oncol. 2026;52:112023.
    

    >> Share

    
    
17. WEI Y, Tian Y, Liu X, Liu G, et al
    Large language model treatment-pathway outputs based on structured clinical text in mid- and low rectal cancer: Concordance with multidisciplinary team decisions and features associated with discordance.
    Eur J Surg Oncol. 2026;52:112053.
    

    >> Share

    
    
18. HOLZE M, Tenckhoff S, Kalkum E, Notheis J, et al
    Patient and public involvement in the co-design of a multicenter randomized controlled trial on prehabilitation: results from the PREHAB-PEER conceptual phase.
    Eur J Surg Oncol. 2026;52:112047.
    

    >> Share

    
    
19. DUMONT F, Raharjo AB, Dumas C, Najem C, et al
    Artificial-intelligence assistance for diagnosis, detection and surgical decision-making in colorectal peritoneal metastases: A cross-sectional BIG-RENAPE pilot study.
    Eur J Surg Oncol. 2026;52:112045.
    

    >> Share

    
    
20. BUONANNO S, Jovine E, Serenari M, Ratti F, et al
    Real-life decision making in use of hypertrophy techniques: agreement in clinical choices based on diagnosis.
    Eur J Surg Oncol. 2026;52:112041.
    

    >> Share

    
    
21. PILZ DA CUNHA G, Balasupramaniam K, Kok N, Verhoef C, et al
    Nationwide strategies and outcomes of minimally invasive versus open combined liver ablation and resection for colorectal liver metastases.
    Eur J Surg Oncol. 2026;52:112075.
    

    >> Share

    
    
22. PEREA J, Spinelli A
    Molecular surgery in colorectal cancer: Integrating genomics into operative decision-making.
    Eur J Surg Oncol. 2026;52:112130.
    

    >> Share

    
    

    
    Int J Cancer

23. SHIN Y, Kim DK, Seo Y, Lee HH, et al
    Evaluation of Mutation Risk Using Patient-Derived Organoids in Patients With Lynch Syndrome.
    Int J Cancer. 2026;159:2585-2594.
    

    >> Share

    
    
24. QUERIDO NR, Bours MJL, Iersel LV, Beijers AJM, et al
    Longitudinal Associations of Oxaliplatin Treatment With Chemotherapy-Induced Peripheral Neuropathy in Colorectal cancer Survivors up to 2 Years Post-Treatment.
    Int J Cancer. 2026 Sep 20. doi: 10.1002/ijc.70745.
    

    >> Share

    
    
25. 
    RETRACTION: MAEL Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Colorectal Cancer.
    Int J Cancer. 2026 Sep 21. doi: 10.1002/ijc.70739.
    

    >> Share

    
    
26. LOFT M, Ganeshanathan V, Wong R, Mendis S, et al
    Concomitant Use of Proton Pump Inhibitors and Survival Outcomes in Patients Receiving Adjuvant Chemotherapy for Stage III Colon Cancer.
    Int J Cancer. 2026 Sep 21. doi: 10.1002/ijc.70754.
    

    >> Share

    
    
27. SITOHY B, Lindmark G, Israelsson A, Olsson L, et al
    Improved Prediction of Colon Cancer Recurrence Using the ColoNode mRNA Test: A 5-Year Survival Analysis.
    Int J Cancer. 2026 Sep 25. doi: 10.1002/ijc.70743.
    

    >> Share

    
    

    
    Int J Colorectal Dis

28. SACHANBINSKI T, Miodonski M, Kropieniewicz J
    Learning curves in Versius-assisted colorectal surgery: a risk-adjusted CUSUM analysis from a single center.
    Int J Colorectal Dis. 2026;41:152.
    

    >> Share

    
    
29. JOHNSEN OF, Riis RN, Meltzer S, Ree AH, et al
    Long-term disease-free survival in young-onset rectal cancer patients surgically treated with curative intent: a retrospective cohort study.
    Int J Colorectal Dis. 2026;41:153.
    

    >> Share

    
    

    
    J Natl Cancer Inst

30. KIM TS, Han K, Oh YE, Kim ER, et al
    Alcohol consumption and colorectal cancer risk in prediabetes and diabetes: a nationwide cohort study.
    J Natl Cancer Inst. 2026 Sep 24:djag340. doi: 10.1093.
    

    >> Share

    
    
31. ZHANG GQ, Ma C, Yang VB, Shi Q, et al
    Physical activity and molecular residual disease in stage III colon cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80702.
    J Natl Cancer Inst. 2026 Sep 24:djag342. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

32. VAN GOOL ISM, van der Klugt J, Gielen C, van Mastrigt GAPG, et al
    Walking to the Operating Room: A Qualitative Study of Colorectal Cancer Patient Experiences in a Dutch Academic Hospital.
    J Surg Oncol. 2026 Sep 25. doi: 10.1002/jso.70381.
    

    >> Share

    
    

    
    Oncogene

33. ZHANG M, Yan D, Zhang J, Gao T, et al
    SETDB1 cooperates with the CRL4B complex to promote colorectal cancer tumorigenesis by disrupting circadian rhythm.
    Oncogene. 2026 Sep 23. doi: 10.1038/s41388-026-03972.
    

    >> Share

    
    

    
    PLoS One

34. TANG B, Chen Y, Yang X, Gong H, et al
    Integrative computational analysis of public fecal lipidomics and transcriptomics datasets suggests a candidate association between the COX-2 pathway and CE(20:4) in colorectal adenoma-carcinoma progression.
    PLoS One. 2026;21:e0358259.
    

    >> Share

    
    
35. MENDALL C, Hullar MAJ, Curtis KR, Hill CM, et al
    Tumor microbial biodiversity and microsatellite instability in colorectal cancer.
    PLoS One. 2026;21:e0359555.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share